Novozymes A/S
NSIS-B
Rangering i aksjer
#821
Established in 1925 and based in Bagsvaerd, Denmark, Novozymes A/S is a global... Established in 1925 and based in Bagsvaerd, Denmark, Novozymes A/S is a global provider of biological solutions, specializing in the development and sale of industrial enzymes, microorganisms, and probiotics. The company's reach extends internationally, serving markets in Denmark, the rest of Europe, North America, Asia Pacific, the Middle East, Africa, and Latin America. Novozymes' diverse portfolio includes protein solutions for the food and beverage sector, alongside a comprehensive suite of cleaning and hygiene offerings for industrial, medical, and household applications, such as drain openers, septic tank treatments, ware washing, and professional laundry. In agriculture, they supply solutions for various crops like corn, cotton, soybeans, and wheat, focusing on bioyield and biocontrol, in addition to animal health and nutrition products and aquaculture systems for warm water species. The company actively supports sustainable industrial processes with contributions to bioenergy (including ethanol, biodiesel, renewable diesel, biogas, and wastewater treatment), biorefining (encompassing fiber modification, bleach boosting, deposit control, starch modification, carbon capture), and applications for textiles and leather. Their extensive range of enzyme solutions, such as lipases, proteases, oxidoreductases, and carbohydrases, are crucial for processes like corn and wheat separation, liquefaction, and saccharification. Furthermore, Novozymes addresses human health with solutions targeting brain, oral, protective, immune, and gastrointestinal well-being, while also engaging in areas like biocatalysis, cell culture, and diagnostics.
Aksjekurs
$70.95
Markedsverdi
$29.27B
Endring (1 dag)
0.94%
Endring (1 år)
11.73%
Land
DK
Handel Novozymes A/S (NSIS-B)
Kategori
Basic Materials
Inntekter for Novozymes A/S (NSIS-B)
Inntekter i Oct 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Novozymes A/S er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Novozymes A/S fra 2002 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2025 | $4.87B | 22.29% |
| 2024 | $3.99B | 50.41% |
| 2023 | $2.65B | 681.55% |
| 2022 | $339.08M | 10.30% |
| 2021 | $307.42M | -86.63% |
| 2020 | $2.30B | 6.62% |
| 2019 | $2.16B | -2.39% |
| 2018 | $2.21B | -5.63% |
| 2017 | $2.34B | 16.67% |
| 2016 | $2.01B | -1.63% |
| 2015 | $2.04B | 0.69% |
| 2014 | $2.03B | -6.45% |
| 2013 | $2.17B | 9.03% |
| 2012 | $1.99B | 707.80% |
| 2011 | $245.94M | -85.90% |
| 2010 | $1.74B | 6.91% |
| 2009 | $1.63B | 7.12% |
| 2008 | $1.52B | 677.27% |
| 2007 | $195.91M | -83.68% |
| 2006 | $1.20B | 20.74% |
| 2005 | $994.18M | -9.18% |
| 2004 | $1.09B | 11.33% |
| 2003 | $983.27M | 23.47% |
| 2002 | $796.36M | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| $35.45B | - |
GB
|
|
| - | - |
FR
|
|
| $24.41B | - |
US
|
|
| $16.84B | - |
US
|
|
| $12.60B | - |
US
|
